Repeatability and reproducibility of rapid T1 mapping of brain tissues at 64 mT: A multicentre study.

Very-low-field MRI (<100 mT) holds promise for Point-of-Care brain imaging applications, including stroke and multiple sclerosis, with T₁ mapping emerging as a key biomarker for brain development and pathology. However, current low-field T₁ mapping protocols suffer from long acquisition times and limited multi-site repeatability. This study aimed to improve T₁ mapping at 64 mT using a clinically feasible 10-minute protocol and assess repeatability and reproducibility across sites. We present an analysis of the repeatability and reproducibility of rapid T₁ measurements in a commercially available phantom and in 60 volunteers, scanned with a portable 64 mT MRI systems at six sites. T₁ mapping was performed using an undersampled 3D inversion-recovery turbo spin-echo sequence with a 10.8-minute scan time, and reconstructed with a locally low-rank approach. Our results in phantom demonstrated high reproducibility in T₁ measurements (below 3% differences from the average), with non-significant differences between sites. Longitudinal measurements demonstrated high repeatability over time both in vivo and in phantom settings in one site, with minimal variability (average Coefficient of Variation of 0.6%). Average in vivo T₁ values for white matter and cortex were 290 ± 6 ms and 332 ± 8 ms, respectively and the values demonstrated high reproducibility, with differences of less than 4% from the average across sites. Our results demonstrate the feasibility of multi-site in vivo T₁ mapping at 64 mT, providing normative T₁ values at this field strength and supporting its use as a quantitative biomarker in clinical applications.